Aptose Biosciences
APTO
#10565
Rank
HK$34.2 M
Marketcap
HK$13.40
Share price
0.00%
Change (1 day)
-42.22%
Change (1 year)

Earnings for Aptose Biosciences (APTO)

Earnings in 2025 (TTM): -HK$0.17 Billion

According to Aptose Biosciences's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -HK$0.2 Billion, an increase over its 2023 earnings that were of -HK$0.42 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aptose Biosciences from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -HK$0.17 Billion-17.59%
2024 -HK$0.2 Billion-51.82%
2023 -HK$0.42 Billion22.9%
2022 -HK$0.34 Billion-34.91%
2021 -HK$0.52 Billion17.36%
2020 -HK$0.44 Billion107.65%
2019 -HK$0.22 Billion-7.73%
2018 -HK$0.23 Billion160.68%
2017 -HK$87.52 Million-20.27%
2016 -HK$0.11 Billion28.71%
2015 -HK$85.29 Million
2013 -HK$48.35 Million
2010 -HK$41.18 Million-8.31%
2009 -HK$44.91 Million
2006 -HK$83.26 Million-156.93%
2005 HK$0.14 B-185.16%
2004 -HK$0.18 Billion458.58%
2003 -HK$30.75 Million-63.66%
2002 -HK$84.6 Million-8.04%
2001 -HK$91.99 Million16.73%
2000 -HK$78.81 Million294.99%
1999 -HK$19.96 Million-6.51%
1998 -HK$21.35 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ImmunoGen
IMGN
-HK$0.5 Billion 200.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Corbus Pharmaceuticals
CRBP
-HK$0.53 Billion 222.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Advaxis
ADXS.defunct
-HK$0.27 Billion 62.62%๐Ÿ‡บ๐Ÿ‡ธ USA